MEDINOX Trademark

Trademark Overview

On Monday, February 13, 1995, a trademark application was filed for MEDINOX with the United States Patent and Trademark Office. The USPTO has given the MEDINOX trademark a serial number of 74633199. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, April 17, 2020. This trademark is owned by MEDINOX, INC.. The MEDINOX trademark is filed in the Pharmaceutical Products category with the following description:

pharmaceutical preparations for the treatment of inflammatory and infectious conditions; medical diagnostic reagents

General Information

Serial Number74633199
Word MarkMEDINOX
Filing DateMonday, February 13, 1995
Status710 - CANCELLED - SECTION 8
Status DateFriday, April 17, 2020
Registration Number2107589
Registration DateTuesday, October 21, 1997
Mark Drawing1000 - Typeset: Word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, August 20, 1996

Trademark Statements

Goods and Servicespharmaceutical preparations for the treatment of inflammatory and infectious conditions; medical diagnostic reagents

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, April 17, 2020
Primary Code005
First Use Anywhere DateSaturday, May 31, 1997
First Use In Commerce DateSaturday, May 31, 1997

Trademark Owner History

Party NameMEDINOX, INC.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92121
Party NameMEDINOX, INC.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92121
Party NameMEDINOX, INC.
Party Type11 - New Owner Before Publication
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92121
Party NameNOT AVAILABLE
Party Type10 - Original Applicant
Legal Entity Type01 - Individual
AddressBrookfield, WI 53045

Trademark Events

Event DateEvent Description
Friday, April 17, 2020CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9
Friday, October 21, 2016COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Tuesday, March 17, 2009REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Tuesday, March 17, 2009REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Wednesday, March 11, 2009FAX RECEIVED
Monday, May 19, 2008RESPONSE RECEIVED TO POST REG. ACTION - SEC. 8 & 9
Monday, May 19, 2008FAX RECEIVED
Tuesday, April 29, 2008POST REGISTRATION ACTION MAILED - SEC. 8 & 9
Tuesday, April 22, 2008ASSIGNED TO PARALEGAL
Tuesday, April 22, 2008ASSIGNED TO PARALEGAL
Friday, April 4, 2008TEAS SECTION 8 & 9 RECEIVED
Friday, March 2, 2007CASE FILE IN TICRS
Wednesday, January 7, 2004REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Friday, October 24, 2003REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED
Tuesday, October 21, 1997REGISTERED-PRINCIPAL REGISTER
Thursday, August 28, 1997ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Thursday, August 28, 1997ASSIGNED TO EXAMINER
Friday, August 22, 1997STATEMENT OF USE PROCESSING COMPLETE
Monday, August 4, 1997USE AMENDMENT FILED
Friday, April 4, 1997EXTENSION 1 GRANTED
Thursday, February 20, 1997EXTENSION 1 FILED
Tuesday, November 12, 1996NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, August 20, 1996PUBLISHED FOR OPPOSITION
Friday, July 19, 1996NOTICE OF PUBLICATION
Monday, June 24, 1996APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, May 28, 1996CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, April 11, 1996LETTER OF SUSPENSION MAILED
Thursday, February 15, 1996ASSIGNED TO EXAMINER
Friday, January 19, 1996CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, July 24, 1995UNRESPONSIVE/DUPLICATE PAPER RECEIVED
Tuesday, July 18, 1995NON-FINAL ACTION MAILED
Friday, June 23, 1995ASSIGNED TO EXAMINER

Related Keywords

medinox medical diagnostic reagents conditions infectious preparations treatment inflammatory pharmaceutical